E-SAR-94010®

Lombardi V.R.M., Cacabelos R. E-SAR-94010: A marine fish extract obtained by advanced biotechnological methods. Drugs Fut 1999, 24(2): 167.

• https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summary_pr?p_JournalId=2&p_RefId=527660&p_IsPs=N

Lombardi VRM, Cagiao A, Fernández-Novoa L, Álvarez XA, Corzo L, Zas R, Sampedro C, Cacabelos R. Short term food supplementation effects of a fish derived extract on the immunological status of pregnant rats and their sucking pups. Nutrition Research 2001, 21(11):1425-1434.

• https://www.sciencedirect.com/science/article/pii/S027153170100361X

Cacabelos R, Vallejo AI, Lombardi VRM, Fernández-Novoa L and Pichel V. E-SAR-94010®: a pleiotropic lipoprotein compound with powerful anti-atheromatous and lipid lowering effects. CNS Drug Reviews 2004, vol. 10 (2).

• https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1527-3458.2004.tb00021.x

Cacabelos R. Role of Nutrition in the Prevention of Alzheimer´s Disease. Aging Health 2005, 1(3): 359-362.

• https://www.futuremedicine.com/doi/abs/10.2217/1745509X.1.3.359

Cacabelos R. Pharmacogenomics, nutrigenomics and therapeutic optimization in Alzheimer’s disease. Aging Health 2005 1:2, 303-348.

• https://www.futuremedicine.com/doi/10.2217/1745509X.1.2.303

Cacabelos R. Application of nutrigenomics to Alzheimer’s disease. Agro Food Industry Hi-Tech. 2008, 19.

Cacabelos R, Cacabelos P, Torrellas C, Tellado I, Carril JC. Pharmacogenomics of Alzheimer’s disease: Novel Therapeutic Strategies for Drug Development. In: Yan Q. (eds) Pharmacogenomics in Drug Discovery and Development. Methods in Molecular Biology (Methods and Protocols), 2014 vol 1175. Humana Press, New York, NY.

• https://link.springer.com/protocol/10.1007%2F978-1-4939-0956-8_13#citeas

Cacabelos R, Fernández-Novoa L, Martínez-Bouza R, McKay A, Carril JC, Lombardi VRM, Corzo L, Carrera I, Tellado I, Nebril L, Alcaraz M, Rodríguez S, et al. Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants. Pharmaceuticals 2010, 3: 3040-3100.

• https://www.mdpi.com/1424-8247/3/10/3040

Cacabelos R. Novel Biotechnological Products from Natural Sources: Nutri/Pharmacogenomic Component. J Nutr Food Sci 2016, 6:6.

• https://www.longdom.org/open-access/novel-biotechnological-products-from-natural-sources-nutri-pharmacogenomic-component-2155-9600-1000e135.pdf

Cacabelos R, Carril JC, Cacabelos P, Teijido O, Goldgaber D. Pharmacogenomics of Alzheimer’s Disease: Genetic Determinants of Phenotypic Variation and Therapeutic Outcome. J Gen Med Pharm 2016, 1(2): 151-209.

• https://www.scitcentral.com/article/20/94/Pharmacogenomics-of-Alzheimer%E2%80%99s-Disease:-Genetic-Determinants-of-Phenotypic-Variation-and-Therapeutic-Outcome

Cacabelos R. ProteoLipins and LipoFishins: Novel nutraceuticals and their effects. Open Access Government. Health & Social Care News 2017, January 20.

• https://www.openaccessgovernment.org/proteolipins-lipofishins-novel-nutraceuticals-effects/31137/

Cacabelos R, Meyyazhagan A, Carril JC, Cacabelos P, Teijido Ó. Pharmacogenetics of Vascular Risk Factors in Alzheimer’s Disease. J. Pers. Med. 2018, 8, 3.

• https://www.mdpi.com/2075-4426/8/1/3

Cacabelos R, Lombardi VRM, Fernández-Novoa l, Carrera I, Cacabelos P, Corzo L, Carril JC, Teijido O. Chapter 6 – Basic and Clinical Studies With Marine LipoFishins and Vegetal Favalins in Neurodegeneration and Age-Related Disorders. Volume 59, 2018, Pages 195-225.

• https://www.sciencedirect.com/science/article/pii/B9780444641793000062

Corzo L, Fernández-Novoa L, Carrera I, Martínez O, Rodríguez S, Alejo R and Cacabelos R. Nutrition, Health, and Disease: Role of Selected Marine and Vegetal Nutraceuticals. Nutrients 2020, 12(3):747.

• https://www.mdpi.com/2072-6643/12/3/747